AVTX
USDAvalo Therapeutics Inc. Common Stock
$16.090-0.270 (-1.650%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$16.360
High
$16.900
Low
$15.810
Volume
0.16M
Company Fundamentals
Market Cap
286.4M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.35M
Exchange
NCM
Currency
USD
52-Week Range
Low $3.39Current $16.090High $19.41
Related News
GlobeNewswire
Avalo Therapeutics to Participate in Upcoming Investor Conferences
WAYNE, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (NASDAQ:AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory
View more
GlobeNewswire
Avalo Therapeutics Announces Completion of Enrollment in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa
WAYNE, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (NASDAQ:AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.